Clinical trialNCT04634916RecruitingInterventional

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

SponsorC. R. BardEnrollment220Arteriovenous FistulaEnd-stage Renal DiseaseKidney Disease, End-Stage

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Eric Peden, MD
The Methodist Hospital Research Institute
Principal Investigator
clinicaltrials.gov ↗
Paul Kreienberg, MD
Albany Medical College
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Southern Adelaide Local Health Network
Bedford Park, South Australia, Australia
Christopher Delaney, MD
Recruiting

United States

California Institute of Renal Research
La Jolla, California, United States
Recruiting
San Francisco Vein & Vascular
San Francisco, California, United States
Daniel Nathanson, MD
Recruiting
First Coast Cardiovascular Institute Pa
Jacksonville, Florida, United States
Yazan Khatib, MD
Recruiting
Radiology and Imaging Specialists
Lakeland, Florida, United States
Recruiting
Vascular and Spine Institute Inc
Miami, Florida, United States
Active, not recruiting
Kidney Care and Transplant Services of Ne
Springfield, Massachusetts, United States
Recruiting
Kidney Care & Transplant Services of New England
West Springfield, Massachusetts, United States
Aleksandr Kurbanov, MD
Recruiting
Umass Chan School of Medicine
Worcester, Massachusetts, United States
Dejah Judelson, MD
Recruiting
Albany Medical Center
Albany, New York, United States
Paul Kreienberg, MD
Recruiting
Nc Nephrology
Raleigh, North Carolina, United States
Completed
Promedica Toledo Hospital
Toledo, Ohio, United States
Mohamed Osman, MD
Recruiting
Butler Memorial Hospital
Butler, Pennsylvania, United States
Brandon Repko, MD
Recruiting
Vascular Institute of Chattanooga
Chattanooga, Tennessee, United States
Christopher Lesar, MD
Recruiting
Bluff City Vascular
Memphis, Tennessee, United States
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Aria Nazeri, MD
Recruiting
Houston Methodist
Houston, Texas, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 26 Mar 2021
Primary completion: 30 Jun 2027
Completion: 30 Sept 2027
Last update posted: 10 Aug 2026
Registered enrollment: 220
Registry id: NCT04634916

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.